RetinaLyze Nordic ApS: Financial statements 2025
CVR: 37219444
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
RetinaLyze Nordic ApS (CVR 37219444) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 213,373 and a net result of DKK 158,437 compared with DKK 145,520 the year before. That is an increase of 14.8% compared with the year before. Equity in the 2025 report amounted to DKK 218,437. The solvency ratio was 43.1%.
- Gross Profit
- DKK 213,373
- Profit/Loss
- DKK 158,437
- Equity
- DKK 218,437
- Total Assets
- DKK 506,251
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | 213K | 158K | 218K | - |
| 2024 | - | 186K | 146K | 206K | - |
| 2023 | - | 332K | 256K | 666K | - |
| 2022 | - | 253K | 192K | 410K | - |
| 2021 | - | 140K | 105K | 218K | - |
Official annual report
How creditworthy is RetinaLyze Nordic ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
RetinaLyze Nordic ApS has published its annual report for 2024. Gross profit came to DKK 185,817, and the net result was DKK 145,520.
About RetinaLyze Nordic ApS
RetinaLyze Nordic ApS is a Danish company of the type Anpartsselskab based in København K, founded in 2015. The company is registered under the industry Ikke-specialiseret engroshandel. The company was previously named UniVision ApS. The management consists of Peter Jørgensen. The company is owned by MountVision ApS. In 2025, the company reported a gross profit of DKK 213,373 and a net result of DKK 158,437 compared with DKK 145,520 the year before. Equity in the 2025 report amounted to DKK 218,437.